Washing our hands of the congenital cytomegalovirus disease epidemic

BMC Public Health

Volumn 5, Issue , 2005, Pages

  Cannon, Michael J ^a,b   Davis, Katherine Finn ^a,c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

BIRTH DEFECT; CONGENITAL INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEVELOPMENTAL DISORDER; EPIDEMIC; HAND WASHING; HEALTH SERVICE; HUMAN; HYGIENE; PHYSICIAN; PREGNANCY; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; UNITED STATES; VIRUS TRANSMISSION; COMPLICATION; CONGENITAL ABNORMALITIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; INFANT; NEWBORN; PATIENT EDUCATION; PREGNANCY COMPLICATIONS, INFECTIOUS; PRESCHOOL CHILD; PREVALENCE; PRIMARY PREVENTION; PROCEDURES; VIROLOGY;

CHILD, PRESCHOOL; CONGENITAL ABNORMALITIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HAND DISINFECTION; HUMANS; INFANT; INFANT, NEWBORN; PATIENT EDUCATION AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PRIMARY PREVENTION; UNITED STATES;

EID: 23944492900     PISSN: 14712458     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-5-70     Document Type: Review

References (57)

1. Centers for Disease Control and Prevention: Progress toward global eradication of poliomyelitis, 2002. MMWR Morb Mortal Wkly Rep 2003, 52:366-369.
2. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L: Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998, 47:1-57.
3. Centers for Disease Control and Prevention: Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children - United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2002, 51:234-237.
4. Hankin JR: Fetal alcohol syndrome prevention research. Alcohol Res Health 2002, 26:58-65.
5. Centers for Disease Control and Prevention: Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 2004, 53:362-365.
6. Sullivan JL, Luzuriaga K: The changing face of pediatric HIV-1 infection. N Engl J Med 2001, 345:1568-1569.
7. Yow MD, Demmler GJ: Congenital cytomegalovirus disease - 20 years is long enough. N Engl J Med 1992, 326:702-703.
8. Institute of Medicine(U.S.) Committee to Study Priorities for Vaccine Development: Vaccines for the 21st Century: A Tool for Decision making Washington D.C., National Academy Press; 2000:460.
9. Dobbins JG, Stewart JA, Demmler GJ: Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group. Mor Mortal Wkly Rep CDC Surveill Summ 1992, 41:35-39.
10. Alford CA, Stagno S, Pass RF, Britt WJ: Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 1990, 12 Suppl 7:S745-S753.
11. Brown HL, Abernathy MP: Cytomegalovirus infection. Semin Perinatol 1998, 22:260-266.
12. Stagno S: Cytomegalovirus. In Infectious diseases of the fetus and newborn infant Edited by: Remington JS and Klein JO. Philadelphia, W.B. Saunders Company; 2001:389-424.
13. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF: Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999, 180:702-707.
14. Pass RF, Stagno S, Dworsky ME, Smith RJ, Alford CA: Excretion of cytomegalovirus in mothers: observations after delivery of congenitally infected and normal infants. J Infect Dis 1982, 146:1-6.
15. Noyola DE, Demmler GJ, Williamson WD, Griesser C, Sellers S, Llorente A, Littman T, Williams S, Jarrett L, Yow MD: Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J 2000, 19:505-510.
16. Montgomery JR, Mason EOJ, Williamson AP, Desmond MM, South MA: Prospective study of congenital cytomegalovirus infection. South Med J 1980, 73:590-3, 595.
17. Murph JR, Souza IE, Dawson JD, Benson P, Petheram SJ, Pfab D, Gregg A, O'Neill ME, Zimmerman B, Bale JFJ: Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol 1998, 147:940-947.
18. Stagno S, Dworsky ME, Torres J, Mesa T, Hirsh T: Prevalence and importance of congenital cytomegalovirus infection in three different populations. J Pediatr 1982, 101:897-900.
19. Pass RF, Hutto C, Ricks R, Cloud GA: Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med 1986, 314:1414-1418.
20. Adler SP: Cytomegalovirus and child day care: risk factors for maternal infection. Pediatr Infect Dis J 1991, 10:590-594.
21. Stagno S, Whitley RJ: Herpesvirus infection of pregnancy. N Engl J Med 1985, 313:1270-1274.
22. Preece PM, Blount JM, Glover J, Fletcher GM, Peckham CS, Griffiths PD: The consequences of primary cytomegalovirus infection in pregnancy. Arch Dis Child 1983, 58:970-975.
23. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA: Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986, 256:1904-1908.
24. Plotkin SA: Is there a formula for an effective CMV vaccine? J Clin Virol 2002, 25:S13 - S21.
25. Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Kiell JM, Soong SJ, Whitley RJ: Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003, 143:16-25.
26. Michaels MG, Greenberg DP, Sabo DL, Wald ER: Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J 2003, 22:504-509.
27. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF: Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997, 130:624-630.
28. Guralnick MJ: Effectiveness of early intervention for vulnerable children: a developmental perspective. Am J Ment Retard 1998, 102:319-345.
29. Kinney JS, Onorato IM, Stewart JA, Pass RF, Stagno S, Cheeseman SH, Chin J, Kumar ML, Yaeger AS, Herrmann KL, .: Cytomegaloviral infection and disease. J Infect Dis 1985, 151:772-774.
30. Onorato IM, Morens DM, Martone WJ, Stansfield SK: Epidemiology of cytomegaloviral infections: recommendations for prevention and control. Rev Infect Dis 1985, 7:479-497.
31. Adler SP, Finney JW, Manganello AM, Best AM: Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr Infect Dis J 1996, 15:240-246.
32. Demmler GJ: Cytomegalovirus. In Textbook of pediatric infectious disease 4th edition. Edited by: Feigin RG and Cherry JD. Philadelphia, W.B. Saunders Company; 1998:1732-1751.
33. American College of Obstetricians and Gynecologists: Perinatal viral and parasitic infections. ACOG Practice Bulletin 20 20th edition. Washington, DC, ACOG; 2000.
34. Vielfaure MKM, Milhalchuk D: Cytomegalovirus: no prevention, no cure. Can Nurse 1995, 91:25-28.
35. Pass RF: Cytomegalovirus infection. Pediatr Rev 2002, 23:163-170.
36. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM: Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002, 57:245-256.
37. Nigro G, Anceschi MM, Cosmi EV: Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG 2003, 110:572-577.
38. Larson E: A causal link between handwashing and risk of infection? Examination of the evidence. Infect Control 1988, 9:28-36.
39. Revello MG, Gerna G: Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002, 15:680-715.
40. Finney JW, Miller KM, Adler SP: Changing protective and risky behaviors to prevent child-to-parent transmission of cytomegalovirus. J Appl Behav Anal 1993, 26:471-472.
41. Adler SP, Finney JW, Manganello AM, Best AM: Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 2004, 145:485-491.
42. Curtis V, Cairncross S: Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis 2003, 3:275-281.
43. Ryan MA, Christian RS, Wohlrabe J: Handwashing and respiratory illness among young adults in military training. Am J Prev Med 2001, 21:79-83.
44. Roberts L, Smith W, Jorm L, Patel M, Douglas RM, McGilchrist C: Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatrics 2000, 105:738-742.
45. Hammond B, Ali Y, Fendler E, Dolan M, Donovan S: Effect of hand sanitizer use on elementary school absenteeism. Am J Infect Control 2000, 28:340-346.
46. Ockene J, Ma Y, Zapka J, Pbert L, Valentine GK, Stoddard A: Spontaneous cessation of smoking and alcohol use among low-income pregnant women. Am J Prev Med 2002, 23:150-159.
47. Lawrence D, Graber JE, Mills SL, Meissner HI, Warnecke R: Smoking cessation interventions in U.S. racial/ethnic minority populations: an assessment of the literature. Prev Med 2003, 36:204-216.
48. Centers for Disease Control and Prevention: CMV. 2004 [http://www.cdc.gov/cmv].
49. Osterholm MT, Reves RR, Murph JR, Pickering LK: Infectious diseases and child day care. Pediatr Infect Dis J 1992, 11:S31 - S41.
50. Smith GC, Pell JP: Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003, 327:1459-1461.
51. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report. 2001, 13(No.2):39.
52. Groseclose SL, Brathwaite WS, Hall PA, Connor FJ, Sharp P, Anderson WJ, Fagan RF, Aponte JJ, Jones GF, Nitschke DA, Chang MH, Doyle T, Dhara R, Jajosky RA, Hatmaker JD: Summary of notifiable diseases - United States, 2002. MMWR Morb Mortal Wkly Rep 2004, 51:1-84.
53. May PA, Gossage JP: Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health 2001, 25:159-167.
54. Habbick BF, Nanson JL, Snyder RE, Casey RE: Mortality in foetal alcohol syndrome. Can J Public Health 1997, 88:181-183.
55. Nembhard WN, Waller DK, Sever LE, Canfield MA: Patterns of first-year survival among infants with selected congenital anomalies in Texas, 1995-1997. Teratology 2001, 64:267-275.
56. Vintzileos AM, Ananth CV, Smulian JC, Day-Salvatore DL, Beazoglou T, Knuppel RA: Cost-benefit analysis of prenatal diagnosis for Down syndrome using the British or the American approach. Obstet Gynecol 2000, 95:577-583.
57. Davidoff MJ, Petrini J, Damus K, Russell RB, Mattison D: Neural tube defect-specific infant mortality in the United States. Teratology 2002, 66 Suppl 1:S17-S22.